DrugPatentWatch

Search for Patents Expiring in 2021

Glossary
Applicant Tradename Generic Name NDA Approval Date Type RLD Patent Number Product Substance Delist Req. Patent Expiration Patented / Exclusive Use
Duramed ResADDERALL 30amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate011522May 12, 1997RXYes6,384,020*PEDYJan 6, 2021
Duramed ResADDERALL 20amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate011522Feb 13, 1996RXNo6,384,020*PEDYJan 6, 2021
Duramed ResADDERALL 15amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate011522Aug 31, 2000RXNo6,384,020*PEDYJan 6, 2021

This preview shows a limited data set. Complete access is available with a Subscription

<- Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
 2000  2001  2002  2003  2004 
 2005  2006  2007  2008  2009 


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright © 2000-2010, thinkBiotech LLC.


[ Home | Site Tour | Plan Comparison | Free Patent Expiration Newsletter | Patent Inventor Report | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
Bookmark or Share This Page ...
[del.icio.us] [Digg] [Reddit] [Facebook] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]